ClearPoint Neuro (CLPT)
(Delayed Data from NSDQ)
$10.53 USD
0.00 (0.00%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $10.53 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLPT 10.53 0.00(0.00%)
Will CLPT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLPT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLPT
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates
CLPT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
Other News for CLPT
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global ...
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
BlackRock, Inc. Acquires Significant Stake in ClearPoint Neuro Inc
ClearPoint Neuro: Consumables Growth Is Promising
ClearPoint Neuro Expands with New Lease Agreement